#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleural mesothelioma Bulbospinal muscular atrophy congenital Malignant glioma Biliary neoplasm Hypoxic-ischaemic encephalopathy Short stature homeobox gene mutation Pseudoxanthoma elasticum Shprintzen-Goldberg syndrome Renal cell carcinoma VEXAS syndrome Myotonia Medulloblastoma Fms-like tyrosine kinase 3 positive Immune thrombocytopenia Sjogren's syndrome More trials…

    Learn about Rare Diseases

    Retinoblastoma – Diagnostics Lysosomal storage disorder Leiomyosarcoma recurrent – Basic Information Haemophagocytic lymphohistiocytosis – Basic Information Mantle cell lymphoma stage IV – Treatment Adrenocortical carcinoma – Trials in Disease Lymphangioma – Trials in Disease Rosai-Dorfman syndrome – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Mucopolysaccharidosis II More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Albaconazole Festuca Rubra Pollen Lansoprazole Permethrin Tamibarotene NORGESTIMATE Juniper Berry Oil Gad20-209-Fsp-A1 Azd5462 Thiocolchicoside RO7268489 Diclofenac Saxagliptin Bemarituzumab Botaretigene Sparoparvovec Sodium Hyaluronate Calcifediol Brepocitinib Tosilate Dried Ferrous Sulfate Mycophenolate Mofetil More therapies…

    Learn about Your Condition

    Lung transplant rejection Carcinoid tumour pulmonary Renal cancer H1N1 influenza Pharyngeal cancer stage III Arterial tortuosity syndrome Stem cell transplant Cervical dysplasia Myocarditis post infection Urethral valves Ovarian epithelial cancer Essential hypertension Diphtheria Rabies Inguinal hernia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of MZE829 capsules for adults with APOL1 kidney disease and protein in urine

    Recruiting

    2 1 1
    Investigated Drugs:
    • MZE829
    France

  • Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments

    Recruiting

    2 1
    Investigated Drugs:
    • Iti-1284
    Bulgaria Czechia Finland Poland Slovakia

  • Study on Long-Term Safety and Effects of Maralixibat for Patients with Alagille Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Alagille syndrome
    Investigated Drugs:
    • MARALIXIBAT
    Belgium France Germany Italy The Netherlands Portugal +1

  • Study of DCC-3116 and ripretinib combination therapy in patients with advanced gastrointestinal stromal tumor (GIST)

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Gastrointestinal stromal tumour
    Investigated Drugs:
    • Ripretinib
    • Dcc-3116
    Denmark France Germany Greece Italy The Netherlands +2

  • Study on Colchicine to Reduce Heart Artery Inflammation in HIV Patients Over 50 with High Cardiovascular Risk

    Recruiting

    2 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Colchicine
    Spain

  • Study on the Safety and Effects of IPN01195 in Adults with Advanced Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • IPN01195
    France Italy Spain
Previous Page
1 … 647 648 649 650 651 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!